Grace Eun Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Grace Eun Lee has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Asuncion Mejias
Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
2 shared publications Briana Sepulveda
University of California Davis California USA
2 shared publications- Christopher B. Forrest
Applied Clinical Research Center, Children's Hospital of Philadelphia
2 shared publications Christopher Blay
University of California San Francisco California USA
2 shared publications- Deepika Thacker
Nemours Cardiac Center, Nemours Childrens Health
2 shared publications - Donald Addington
Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
2 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 20 (3) , e70151
Adaptation of the First Episode Psychosis Services—Fidelity Scale for Use in New and Small Programs
Introduction: Fidelity assessments can support healthcare services to deliver care consistent with best practises. However, early psychosis (EP) fidelity assessment tools typically require a volume of service data that is often unavailable to small or new programmes. In this study, we pilot a formative fidelity assessment approach to address these challenges. Methods: A formative assessment approach to using the First Episode Psychosis Services—Fidelity Scale (FEPS‐FS) was developed to enable the assessment of small and new EP programmes. Over 48 months, EPI‐CAL EP learning health care network programmes completed standard FEPS‐FS fidelity assessments, formative assessments for new programmes, or formative assessments for small programmes, depending upon programme eligibility. Results: Of 27 remote fidelity assessments completed with EP programmes across California, nine (33.3%) had insufficient service data to complete a standard FEPS‐FS assessment. Utilising the proposed formative assessment approach, one programme met the criteria for a new programme assessment, and seven for a small programme assessment. In the new programme assessment approach, 34 of 36 items could be assessed. In the small programme assessments, a median of 19 items was scored, with a mean FEPS‐FS score range from 3.45 to 4.12. Conclusion: These findings suggest that a formative approach to fidelity assessment can generate a meaningful amount of data, capture known variability between programmes, and potentially identify areas for service improvement to enhance quality for small and new programmes. However, critical data regarding the delivery of pharmacological and psychosocial care were not captured, highlighting the limitations of the approach.
- 10 March 2026
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 20 (3) , e70151
Open AccessAdaptation of the First Episode Psychosis Services—Fidelity Scale for Use in New and Small Programs
Introduction: Fidelity assessments can support healthcare services to deliver care consistent with best practises. However, early psychosis (EP) fidelity assessment tools typically require a volume of service data that is often unavailable to small or new programmes. In this study, we pilot a formative fidelity assessment approach to address these challenges. Methods: A formative assessment approach to using the First Episode Psychosis Services—Fidelity Scale (FEPS‐FS) was developed to enable the assessment of small and new EP programmes. Over 48 months, EPI‐CAL EP learning health care network programmes completed standard FEPS‐FS fidelity assessments, formative assessments for new programmes, or formative assessments for small programmes, depending upon programme eligibility. Results: Of 27 remote fidelity assessments completed with EP programmes across California, nine (33.3%) had insufficient service data to complete a standard FEPS‐FS assessment. Utilising the proposed formative assessment approach, one programme met the criteria for a new programme assessment, and seven for a small programme assessment. In the new programme assessment approach, 34 of 36 items could be assessed. In the small programme assessments, a median of 19 items was scored, with a mean FEPS‐FS score range from 3.45 to 4.12. Conclusion: These findings suggest that a formative approach to fidelity assessment can generate a meaningful amount of data, capture known variability between programmes, and potentially identify areas for service improvement to enhance quality for small and new programmes. However, critical data regarding the delivery of pharmacological and psychosocial care were not captured, highlighting the limitations of the approach.
- Open Access
- 5 September 2025
- Published by Wiley
Adaptation of the First Episode Psychosis Services -- Fidelity Scale for use in New and Small Programs
Introduction: Fidelity assessments can support healthcare services to deliver care consistent with best practices. However, early psychosis (EP) fidelity assessment tools typically require a volume of service data that is often unavailable to small or new programs. In this study, we pilot a formative fidelity assessment approach to address these challenges. Methods: A formative assessment approach to using the First Episode Psychosis Services – Fidelity Scale (FEPS-FS) was developed to enable the assessment of small and new EP programs. Over 48 months, EPI-CAL EP learning health care network programs completed standard FEPS-FS fidelity assessments, formative assessments for new programs, or formative assessments for small programs, depending upon program eligibility. Results: Of 27 remote fidelity assessments completed with EP programs across California, nine (33.3%) had insufficient service data to complete a standard FEPS-FS assessment. Utilizing the proposed formative assessment approach, one program met the criteria for a new program assessment, and seven a small program assessment. In the new program assessment approach, 34 of 36 items could be assessed. In the small program assessments, a median of 19 items was scored, with a mean FEPS-FS score range from 3.45 to 4.12. Conclusion: These findings suggest that a formative approach to fidelity assessment can generate a meaningful amount of data, capture known variability between programs, and potentially identify areas for service improvement to enhance quality for small and new programs. However, critical data regarding the delivery of pharmacological and psychosocial care were not captured, highlighting the limitations of the approach.
- 5 September 2025
- Published by Wiley
Open AccessAdaptation of the First Episode Psychosis Services -- Fidelity Scale for use in New and Small Programs
Introduction: Fidelity assessments can support healthcare services to deliver care consistent with best practices. However, early psychosis (EP) fidelity assessment tools typically require a volume of service data that is often unavailable to small or new programs. In this study, we pilot a formative fidelity assessment approach to address these challenges. Methods: A formative assessment approach to using the First Episode Psychosis Services – Fidelity Scale (FEPS-FS) was developed to enable the assessment of small and new EP programs. Over 48 months, EPI-CAL EP learning health care network programs completed standard FEPS-FS fidelity assessments, formative assessments for new programs, or formative assessments for small programs, depending upon program eligibility. Results: Of 27 remote fidelity assessments completed with EP programs across California, nine (33.3%) had insufficient service data to complete a standard FEPS-FS assessment. Utilizing the proposed formative assessment approach, one program met the criteria for a new program assessment, and seven a small program assessment. In the new program assessment approach, 34 of 36 items could be assessed. In the small program assessments, a median of 19 items was scored, with a mean FEPS-FS score range from 3.45 to 4.12. Conclusion: These findings suggest that a formative approach to fidelity assessment can generate a meaningful amount of data, capture known variability between programs, and potentially identify areas for service improvement to enhance quality for small and new programs. However, critical data regarding the delivery of pharmacological and psychosocial care were not captured, highlighting the limitations of the approach.
- Open Access
- 9 August 2023
- Published by Wiley in Pediatric Diabetes
- Vol. 2023, 1-10
Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program
Background. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) is associated with worsening diabetes trajectory. It is unknown whether PASC in children with type 1 diabetes (T1D) manifests as worsening diabetes trajectory. Objective. To explore the association between SARS-CoV-2 infection (COVID-19) and T1D-related healthcare utilization (for diabetic ketoacidosis (DKA) or severe hypoglycemia (SH)) or hemoglobin (Hb) A1c trajectory. Methods: We included children Results. From March 01, 2020 to June 22, 2022, 2,404 and 1,221 youth met entry criteria for the Broad and Narrow Cohorts, respectively. The hazard ratio for utilization was (HR 1.45 (95% CI: 0.97, 2.16)). In the Narrow Cohort, the rate of change (slope) of HbA1c increased 91–180 days after cohort entry for those with COVID-19 (0.138 vs. −0.002, ). Beyond 180 days, greater declines in HbA1c were observed in the positive cohort (−0.104 vs. 0.008 per month, ). Conclusion. While a trend toward worse outcomes following COVID-19 in T1D patients was observed, these findings were not statistically significant. Continued clinical monitoring of youth with T1D following COVID-19 is warranted.
- 9 August 2023
- Published by Wiley in Pediatric Diabetes
- Vol. 2023, 1-10
Open AccessImpact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program
Background. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) is associated with worsening diabetes trajectory. It is unknown whether PASC in children with type 1 diabetes (T1D) manifests as worsening diabetes trajectory. Objective. To explore the association between SARS-CoV-2 infection (COVID-19) and T1D-related healthcare utilization (for diabetic ketoacidosis (DKA) or severe hypoglycemia (SH)) or hemoglobin (Hb) A1c trajectory. Methods: We included children Results. From March 01, 2020 to June 22, 2022, 2,404 and 1,221 youth met entry criteria for the Broad and Narrow Cohorts, respectively. The hazard ratio for utilization was (HR 1.45 (95% CI: 0.97, 2.16)). In the Narrow Cohort, the rate of change (slope) of HbA1c increased 91–180 days after cohort entry for those with COVID-19 (0.138 vs. −0.002, ). Beyond 180 days, greater declines in HbA1c were observed in the positive cohort (−0.104 vs. 0.008 per month, ). Conclusion. While a trend toward worse outcomes following COVID-19 in T1D patients was observed, these findings were not statistically significant. Continued clinical monitoring of youth with T1D following COVID-19 is warranted.
- Open Access
Impact of SARS-CoV-2 infection on disease trajectory in youth with T1D: An EHR-based cohort study from the RECOVER program
Background Post-acute sequelae of SARS-Co-V-2 infection (PASC) is associated with worsening diabetes trajectory. It is unknown whether PASC in children with type 1 diabetes (T1D) manifests as worsening diabetes trajectory. Objective To explore the association between SARS-CoV-2 infection (COVID-19) and T1D-related healthcare utilization (for diabetic ketoacidosis [DKA] or severe hypoglycemia [SH]) or Hemoglobin (Hb) A1c trajectory. Methods We included children Results From 03/01/2020-06/22/2022, 2,404 and 1,221 youth met entry criteria for the Broad and Narrow cohorts, respectively. The hazard ratio for utilization was (HR 1.45 [95%CI,0.97,2.16]). In the Narrow Cohort, the rate of change (slope) of HbA1c increased 91-180 days after cohort entry for those with COVID-19 (0.138 vs. -0.002, p=0.172). Beyond 180 days, greater declines in HbA1c were observed in the positive cohort (-0.104 vs. 0.008 per month, p=0.024). Conclusion While a trend towards worse outcomes following COVID-19 in T1D patients was observed, these findings were not statistically significant. Continued clinical monitoring of youth with T1D following COVID-19 is warranted. Authorship Statement Authorship has been determined according to ICMJE recommendations Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH or other funders. Funding Source ⍰This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research.
Open AccessImpact of SARS-CoV-2 infection on disease trajectory in youth with T1D: An EHR-based cohort study from the RECOVER program
Background Post-acute sequelae of SARS-Co-V-2 infection (PASC) is associated with worsening diabetes trajectory. It is unknown whether PASC in children with type 1 diabetes (T1D) manifests as worsening diabetes trajectory. Objective To explore the association between SARS-CoV-2 infection (COVID-19) and T1D-related healthcare utilization (for diabetic ketoacidosis [DKA] or severe hypoglycemia [SH]) or Hemoglobin (Hb) A1c trajectory. Methods We included children Results From 03/01/2020-06/22/2022, 2,404 and 1,221 youth met entry criteria for the Broad and Narrow cohorts, respectively. The hazard ratio for utilization was (HR 1.45 [95%CI,0.97,2.16]). In the Narrow Cohort, the rate of change (slope) of HbA1c increased 91-180 days after cohort entry for those with COVID-19 (0.138 vs. -0.002, p=0.172). Beyond 180 days, greater declines in HbA1c were observed in the positive cohort (-0.104 vs. 0.008 per month, p=0.024). Conclusion While a trend towards worse outcomes following COVID-19 in T1D patients was observed, these findings were not statistically significant. Continued clinical monitoring of youth with T1D following COVID-19 is warranted. Authorship Statement Authorship has been determined according to ICMJE recommendations Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH or other funders. Funding Source ⍰This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research.
- 1 October 2021
- Published by American Psychological Association (APA) in Cultural Diversity & Ethnic Minority Psychology
- Vol. 27 (4) , 728-735
Testimony and meaning: A qualitative study of Black women with cancer diagnoses.
Objective: Research has established religion and spirituality as important resources for Black people in the U.S. coping with adversity. Most research has been from an etic perspective, examining religious variables that are valid across multiple religions. In the present study, we asked what emic aspects of the Black church's practices and theological emphases women with cancer drew on in constructing meaning-making narratives from their cancer experience. Method: In this consensual qualitative research study, we interviewed 30 Black women with cancer histories with an average age of 64.5. Results: The religious practice of testimony emerged as the predominant theme. Testimony (a) provided a meaningful purpose to the cancer experience; (b) had a specific content of describing what God had done in their lives as well as some common theological emphases; (c) had dual desired outcomes of helping others and bringing glory to God; and (d) had an associated practice of giving testimony. Conclusion: We discuss testimony as a narrative structure and highlight its importance in informing culturally sensitive interventions aimed at supporting Black women with cancer.
- 1 October 2021
- Published by American Psychological Association (APA) in Cultural Diversity & Ethnic Minority Psychology
- Vol. 27 (4) , 728-735
Testimony and meaning: A qualitative study of Black women with cancer diagnoses.
Objective: Research has established religion and spirituality as important resources for Black people in the U.S. coping with adversity. Most research has been from an etic perspective, examining religious variables that are valid across multiple religions. In the present study, we asked what emic aspects of the Black church's practices and theological emphases women with cancer drew on in constructing meaning-making narratives from their cancer experience. Method: In this consensual qualitative research study, we interviewed 30 Black women with cancer histories with an average age of 64.5. Results: The religious practice of testimony emerged as the predominant theme. Testimony (a) provided a meaningful purpose to the cancer experience; (b) had a specific content of describing what God had done in their lives as well as some common theological emphases; (c) had dual desired outcomes of helping others and bringing glory to God; and (d) had an associated practice of giving testimony. Conclusion: We discuss testimony as a narrative structure and highlight its importance in informing culturally sensitive interventions aimed at supporting Black women with cancer.